CN102579662A - Medicinal composition for treating dairy cattle mammitis - Google Patents
Medicinal composition for treating dairy cattle mammitis Download PDFInfo
- Publication number
- CN102579662A CN102579662A CN2012100722846A CN201210072284A CN102579662A CN 102579662 A CN102579662 A CN 102579662A CN 2012100722846 A CN2012100722846 A CN 2012100722846A CN 201210072284 A CN201210072284 A CN 201210072284A CN 102579662 A CN102579662 A CN 102579662A
- Authority
- CN
- China
- Prior art keywords
- parts
- mammitis
- raw materials
- radix
- following raw
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicinal composition for treating dairy cattle mammitis, and belongs to the field of animal health-care products. The medicinal composition comprises the following raw materials (which contain processed products) or extracts of the following raw materials (which contain the processed products) or chemically-acceptable derivatives of the extracts of the following raw materials (which contain the processed products) in part by weight: 50 to 120 parts of Mongolian dandelion herb, 50 to 120 parts of baical skullcap root, 50 to 120 parts of honeysuckle, 50 to 120 parts of weeping forsythia, 50 to 120 parts of wild chrysanthemum flower, 50 to 120 parts of heartleaf houttuynia herb, 50 to 120 parts of largehead atractylodes rhizome, 50 to 120 parts of beautiful sweetgum fruit, 50 to 120 parts of liquoric root, 50 to 120 parts of cowherb seed, 50 to 120 parts of astragalus, 50 to 120 parts of Chinese angelica, 50 to 120 parts of gensing, 50 to 120 parts of akebia stem and 50 to 120 parts of himalayan teasel root. The medicinal composition for treating dairy cattle mammitis does not contain chemical medicines, belongs to a pure Chinese medicinal preparation, is efficient, safe and non-toxic and does not influence food safety, and the airy cattle mammitis is treated comprehensively in aspects of improving diseases, reducing irritation, regulating immunity and the like.
Description
Technical field
The invention belongs to animal health article field, the product that provides is used to treat acute mammitis of cow, chronic mammitis, latent mammitis, and female animal vaginitis, metritis.
Background technology
Current, people are increasing to the dairy products demand, and all kinds of crowds all have needs, particularly infant.After " Sanlu incident ", the Chinese government is more and more tighter to the milk product security control, and examination criteria is increasingly high, and wherein the detection of antibiotic remains is exactly an important control measure to the milk products source.This raw milk that just requires milk cattle cultivating enterprise to be sold can not have antibiotic remains.And the main medicine of current treatment mammitis of cow is exactly an antibiotic, although stipulated strict abandoning the milk phase after the medication, the antibiotic incident that exceeds standard still takes place again and again in the milk product.Want to solve this contradiction, control milk Chinese medicine is residual from the source, must seek new medicine source, replaces antibiotic to be used to treat mammitis of cow.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine composition, is used to treat acute mammitis of cow, chronic mammitis, latent mammitis, and female animal vaginitis, metritis.
Treatment mammitis of cow medicine provided by the present invention does not contain any chemicals, belongs to pure Chinese medicinal preparation, and from improving disease, reducing aspect Comprehensive Treatment mammitis of cow such as stimulating, regulate immunity, efficient and safety non-toxic does not influence food safety.
A kind of pharmaceutical composition of treating mammitis of cow contains the derivant of the form of chemically can accepting of extract or following raw materials according (containing processed product) extract of raw material (containing processed product) or the following raw materials according (containing processed product) of following consumption: 50～100 parts of Herba Taraxacis, 50～150 parts of Radix Scutellariaes, 40～120 parts of Flos Loniceraes; 40～120 parts of Fructus Forsythiaes, 40～120 parts of Flos Chrysanthemi Indicis, 40～120 parts of Herba Houttuyniae; 40～120 parts of the Rhizoma Atractylodis Macrocephalaes, 50～120 parts of Fructus Liquidambaris, 50～150 parts in Radix Glycyrrhizae; 50～90 parts of Semen Vaccariae, 30～120 parts of the Radixs Astragali, 50～120 parts of Radix Angelicae Sinensis; 30～90 parts of Radix Codonopsis, 20～60 parts of Caulis Akebiaes, 50～120 parts of Radix Dipsacis.
Compositions method for using according to the invention and use amount are: press 500g/ time consumption, irritate clothes behind the poach; Perhaps said composition is processed injection, press the intramuscular injection of 0.1ml/kg body weight, perhaps said composition is processed breast perfusion preparation, pour into by 10ml/ breast pond.
Compositions of the present invention; Have clearing away heat and promoting diuresis, dredging collateral for promoting lactation, the merit of the desilting of invigorating blood circulation, strengthening by means of tonics; Can be from improving disease, reduce to stimulate, regulate aspect Comprehensive Treatment acute mammitis of cow, chronic mammitis, latent mammitises such as immunity, and female animal vaginitis, metritis etc., safety non-toxic; Do not influence food safety, stop antibiotic remains from the source.
The specific embodiment
Embodiment 1: 100 parts of Herba Taraxacis, and 90 parts of Radix Scutellariaes, 45 parts of Flos Loniceraes, 45 parts of Fructus Forsythiaes, 60 parts of the Radixs Astragali, 50 parts of Radix Angelicae Sinensis, subsequent use after pulverizing.
Embodiment 2: 100 parts of Herba Taraxacis, and 50 parts of Radix Scutellariaes, 25 parts of Flos Loniceraes, 25 parts of Fructus Forsythiaes, 30 parts of the Radixs Astragali, 50 parts of Radix Angelicae Sinensis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Radix Codonopsis, it is subsequent use that above composition extracts back (the 1ml medicinal liquid is equivalent to the 2g raw medicinal herbs).
Embodiment 3: 100 parts of Herba Taraxacis, 35 parts of Flos Chrysanthemi Indicis, 70 parts of Herba Houttuyniae, 45 parts of the Rhizoma Atractylodis Macrocephalaes, 35 parts of Fructus Liquidambaris, 40 parts in Radix Glycyrrhizae, 45 parts of Semen Vaccariae, 50 parts of the Radixs Astragali.Above composition pulverizing back mix homogeneously is subsequent use or extraction back (the 1ml medicinal liquid is equivalent to the 2g raw medicinal herbs) is subsequent use.
Embodiment 4: 100 parts of Herba Taraxacis, 15 parts of Herba Houttuyniae, 25 parts of the Rhizoma Atractylodis Macrocephalaes, 40 parts of Fructus Liquidambaris, 40 parts in Radix Glycyrrhizae, 35 parts of Semen Vaccariae, 40 parts of the Radixs Astragali, 35 parts of Radix Angelicae Sinensis, 15 parts of Radix Codonopsis, 20 parts of Caulis Akebiaes, 25 parts of Radix Dipsacis.Above composition pulverizing back mix homogeneously is subsequent use or extraction back (the 1ml medicinal liquid is equivalent to the 1g raw medicinal herbs) is subsequent use.
Above embodiment has been merely the present invention has been further described, and scope of the present invention does not receive the limitation of the embodiment that lifts.
The part test final report:
A kind of test report of treating the pharmaceutical composition of mammitis of cow
The milk cattle cultivating field uses these article and other mammitis of cow medicines to adopt perfusion treatment mammitis of cow.
First selects for use certain to make a definite diagnosis 39 of milch cows that suffer from mastitis, is divided into two groups at random.Pour into this extract and injection ceftiofur sodium respectively; Select for use certain to make a definite diagnosis 25 of milch cows that suffer from mastitis, pour into 30% lincomycin hydrochloride injection for second batch; Select for use certain to make a definite diagnosis 43 of milch cows that suffer from mastitis for the 3rd batch, be divided into two groups at random, add perfusion injection amoxicillin and 10% ciprofloxacin lactate injection respectively.More than the test medicament is researched and developed laboratory by Guangdong Zijin positive day pharmaceutcal corporation, Ltd, positive sky-Hua Nongxin veterinary drug and is united and provide.
Five groups of treatments of table 1 comparative test result
| Project | These article group | The ceftiofur group | The lincomycin group | The amoxicillin group | The ciprofloxacin group |
| Sample number (head) | 20 | 19 | 25 | 22 | 21 |
| Cure quantity (head) | 20 | 18 | 23 | 20 | 18 |
| Cure rate | 100.0% | 94.7% | 92.0% | 90.9% | 85.7% |
Five groups of antibiotic remains comparative test result of table 2
| Project | These article group | The ceftiofur group | The lincomycin group | The amoxicillin group | The ciprofloxacin group |
| 1 hour | Qualified | Defective | Defective | Defective | Defective |
| 12 hours | Qualified | Defective | Defective | Defective | Defective |
| 24 hours | Qualified | Qualified | Defective | Defective | Defective |
| 36 hours | Qualified | Qualified | Qualified | Defective | Defective |
| 48 hours | Qualified | Qualified | Qualified | Defective | Defective |
| 60 hours | Qualified | Qualified | Qualified | Qualified | Defective |
| 72 hours | Qualified | Qualified | Qualified | Qualified | Qualified |
Annotate: these article carry out antibiotic at 1 hour after milking of perfusion and detect, and testing result is qualified, shows that these article do not contain antibiotic.
Can find out that by table 1, table 2 used the milch cow that suffers from mastitis of this kind combination treatment, its cure rate is high than the other drug group, and the milk detecting antibiotic-free that produces.Explain that this kind compositions can be used for treating mammitis of cow, have efficient quick, characteristics with low cost.
Claims (3)
1. pharmaceutical composition of treating mammitis of cow contains the derivant of the form of chemically can accepting of extract or following raw materials according (containing processed product) extract of raw material (containing processed product) or the following raw materials according (containing processed product) of following consumption: 50～100 parts of Herba Taraxacis, 50～150 parts of Radix Scutellariaes, 40～120 parts of Flos Loniceraes; 40～120 parts of Fructus Forsythiaes, 40～120 parts of Flos Chrysanthemi Indicis, 40～120 parts of Herba Houttuyniae; 40～120 parts of the Rhizoma Atractylodis Macrocephalaes, 50～120 parts of Fructus Liquidambaris, 50～150 parts in Radix Glycyrrhizae; 50～90 parts of Semen Vaccariae, 30～120 parts of the Radixs Astragali, 50～120 parts of Radix Angelicae Sinensis; 30～90 parts of Radix Codonopsis, 20～60 parts of Caulis Akebiaes, 50～120 parts of Radix Dipsacis.
2. a kind of pharmaceutical composition of treating mammitis of cow according to claim 1, its method for using and use amount are: press 500g/ time consumption, irritate clothes behind the poach; Perhaps said composition is processed injection, press the intramuscular injection of 0.1ml/kg body weight, perhaps said composition is processed breast perfusion preparation, pour into by 10ml/ breast pond.
3. a kind of pharmaceutical composition of treating mammitis of cow according to claim 1 is characterized in that processing clinical suitable forms such as powder, solution, injection, transdermal agent, breast perfusion preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100722846A CN102579662A (en) | 2012-03-19 | 2012-03-19 | Medicinal composition for treating dairy cattle mammitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100722846A CN102579662A (en) | 2012-03-19 | 2012-03-19 | Medicinal composition for treating dairy cattle mammitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102579662A true CN102579662A (en) | 2012-07-18 |
Family
ID=46469264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100722846A Pending CN102579662A (en) | 2012-03-19 | 2012-03-19 | Medicinal composition for treating dairy cattle mammitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102579662A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191300A (en) * | 2013-04-02 | 2013-07-10 | 山东新希望六和集团有限公司 | External preparation of traditional Chinese medicine composition with immune function for treating dairy cow mastitis |
| CN104161176A (en) * | 2013-07-15 | 2014-11-26 | 河南联合英伟饲料有限公司 | Traditional Chinese medicine feed additive for effectively preventing dairy cow mastitis |
| CN104431485A (en) * | 2014-11-29 | 2015-03-25 | 汝州羊羊羊牧业科技有限公司 | Feed for cattle and sheep in lactation period |
| CN105106293A (en) * | 2015-09-15 | 2015-12-02 | 临汾市尧都区傲康养殖发展有限公司 | Traditional Chinese medicine composition for milk cow mastitis |
| CN106177754A (en) * | 2016-07-14 | 2016-12-07 | 宁波科瑞特动物药业有限公司 | A kind of prevention, treatment sow and the compositions of mammitis of cow |
| CN106421522A (en) * | 2016-10-27 | 2017-02-22 | 赵林 | Special medicinal preparation for preventing and treating dairy cow mastitis |
| CN111529588A (en) * | 2020-05-13 | 2020-08-14 | 河北冀丰动物营养科技有限责任公司 | Traditional Chinese medicine composition for treating cow mastitis and preparation method thereof |
-
2012
- 2012-03-19 CN CN2012100722846A patent/CN102579662A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103191300A (en) * | 2013-04-02 | 2013-07-10 | 山东新希望六和集团有限公司 | External preparation of traditional Chinese medicine composition with immune function for treating dairy cow mastitis |
| CN104161176A (en) * | 2013-07-15 | 2014-11-26 | 河南联合英伟饲料有限公司 | Traditional Chinese medicine feed additive for effectively preventing dairy cow mastitis |
| CN104431485A (en) * | 2014-11-29 | 2015-03-25 | 汝州羊羊羊牧业科技有限公司 | Feed for cattle and sheep in lactation period |
| CN105106293A (en) * | 2015-09-15 | 2015-12-02 | 临汾市尧都区傲康养殖发展有限公司 | Traditional Chinese medicine composition for milk cow mastitis |
| CN106177754A (en) * | 2016-07-14 | 2016-12-07 | 宁波科瑞特动物药业有限公司 | A kind of prevention, treatment sow and the compositions of mammitis of cow |
| CN106421522A (en) * | 2016-10-27 | 2017-02-22 | 赵林 | Special medicinal preparation for preventing and treating dairy cow mastitis |
| CN111529588A (en) * | 2020-05-13 | 2020-08-14 | 河北冀丰动物营养科技有限责任公司 | Traditional Chinese medicine composition for treating cow mastitis and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579662A (en) | Medicinal composition for treating dairy cattle mammitis | |
| CN103751497A (en) | Medicament for treating mastitis and preparation method thereof | |
| CN104435594A (en) | Medicine for treating viral hemorrhagic disease of trionyx sinensis | |
| CN104435632A (en) | Traditional Chinese medicine prescription for treating red-neck disease of soft-shelled turtles and preparation method thereof | |
| CN101991744B (en) | Traditional Chinese medicine perfusion agent for treating milk cow endometritis | |
| CN104367746A (en) | Compound traditional Chinese medicine perfusion agent used for treating endometritis of dairy cow and preparation method of compound traditional Chinese medicine perfusion agent | |
| CN104474233A (en) | Formula and preparation method of trionyx sinensis skin fester disease treating traditional Chinese medicine | |
| CN104435634A (en) | Medicine for treating white-spot disease caused by aeromonas | |
| CN102895584A (en) | Traditional Chinese medicine preparation for enhancing pig antibiosis and anti-virus, and preparation method thereof | |
| CN104940404A (en) | Preparation for preventing pullorum disease and preparation method | |
| CN100471510C (en) | Combination of lmedication for treatig mastitis of cow and preparation method | |
| CN104288423A (en) | Oral liquid for treating dairy cattle kidney-yang deficiency type ovarian infertility and preparation method of oral liquid | |
| CN104524555A (en) | Traditional Chinese medicinal oral liquid for enhancing livestock and poultry immunity and preparation method of oral liquid | |
| CN104435252A (en) | Medicine for treating acute mastitis | |
| CN104306531A (en) | Traditional Chinese medicine used for treating vascular nevus | |
| CN104027522A (en) | Traditional Chinese medicament for treating acute appendicitis | |
| CN103893502A (en) | Traditional Chinese medicine for treating phlyctenular conjunctivitis | |
| CN102670793A (en) | Chinese herba preparation for increasing cow immunity and reducing milk somatic number and preparation method | |
| CN112957420A (en) | Traditional Chinese medicine health-care preparation and feed for pigs as well as preparation method and application of traditional Chinese medicine health-care preparation and feed | |
| CN106822528A (en) | Treat traditional Chinese medicine oral liquid of sow Postpartum anestrus and preparation method thereof | |
| CN102302575B (en) | Oral medicament for treating white scour of piglets and preparation method thereof | |
| CN104784300A (en) | Traditional Chinese medicinal formula for preventing and treating postpartum mastitis of dairy cow | |
| CN102579731B (en) | Chinese herbal preparation for treating chronic respiratory diseases | |
| CN104352607A (en) | Oral liquid for treating qi stagnation and blood stasis type ovarian infertility of milk cows and preparation method of oral liquid | |
| CN104436029A (en) | Drug for treating pelvic inflammatory disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120718 |